The study of mRNA Expression of Dopamine Receptors D2 and D3 in Schizophrenic Patients

SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL

Dehydroepiandrosterone sulfate and testosterone levels correlate with negative symptoms in male patients with schizophrenia

Cytokine profile among a sample of bipolar and schizophrenic patients: a comparative study

Correlations between Serum Levels of Interleukin-2 and Different Symptoms of Schizophrenic Disorders

DETECTION OF AUTISITC LIKE TRAITS IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR DISORDERS

A NEW SCAFFOLD FOR D3 DOPAMINERGIC AFFINITY CONTAINING ARYLPIPERAZINE FRAGMENT: MOLECULAR MODELING, SYNTHESIS, IN VITRO AND IN VIVO PHARMACOLOGICAL EVALUATION

Schizophrenia resistance: is there a difference?

STUDY OF THE DOPAMINE TRANSPORTER GENE (DAT1) POLYMORPHISM AND SEROTONIN TRANSPORTER PROMOTER GENE IN PATIENTS WITH LIFELONG PREMATURE EJACULATION AND ITS RELATION TO THE RESPONS

CRP and its relation to cognitive performance in schizophrenia patients: a cross-sectional study